Latest Regulatory Challenges News

Shekel Brainweigh Ltd has requested an immediate suspension from ASX quotation as it moves towards removal from the official ASX list, raising questions about the company’s future.

VRX Silica Limited's Arrowsmith North silica sand project faces a formal appeal from the Conservation Council of WA, challenging the recent environmental approval recommendation. The company is preparing its response while continuing to advance parallel permitting processes.

Vonex Limited has announced a $13.9 million non-renounceable entitlement offer to reduce its substantial debt, with major shareholder Maxo Telecommunications underwriting the raise. The move comes as CEO Ian Porter prepares to depart, marking a pivotal moment for the telecommunications provider.

Emyria reports sustained and statistically significant improvements in PTSD symptoms and quality of life three months after MDMA-assisted therapy, signaling a potential breakthrough for treatment-resistant patients.

ANTAM has reported an all-time high in gold sales for FY24 alongside robust production in nickel and bauxite, underpinned by strategic partnerships and a strong sustainability agenda.

EMU NL has made significant strides in its Yataga Copper Project exploration, completing key geochemical and geophysical surveys and securing $1.5 million through a share placement. The company is poised to identify high-priority drill targets in the first half of 2025.

Bounty Oil and Gas NL reports steady cash reserves and rising oil production in Queensland, while facing regulatory setbacks offshore. The company’s strategic developments and entitlement offer position it for growth in 2025.

Magnis Energy Technologies reports ongoing progress on its Nachu Graphite Project while grappling with Imperium3’s bankruptcy and a prolonged ASX trading suspension.

Golden Cross Resources continues to push forward with joint venture discussions to finance its flagship Copper Hill project, while planning extensive geophysical surveys and addressing regulatory challenges.

BOA Resources Limited reveals its strategic drilling plans for 2025 targeting key lithium and nickel tenements in Western Australia, alongside a refreshed board and ongoing asset optimisation.

C29 Metals closes December quarter with $2.56 million cash and key drilling approvals for its Ulytau uranium project, but faces a significant hurdle after Ministerial refusal to transfer ownership of its Kazakhstan tenement.

Mesoblast Limited is set to launch Ryoncil®, the first FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease, backed by a recent $160 million financing that strengthens its commercial and clinical development efforts.